In this episode we’re continuing our look at the innate immune system by considering the potential of Natural Killer or NK cells for cancer immunotherapy:

Why do NK cells matter, what do they see, and how can then be targeted?

Just like with T cells, it turns out there are a number of different therapeutic approaches that can be used for NK cells, ranging from allogeneic cell therapies and CAR NK cells to BiKEs, TriKEs, as well as monoclonal antibodies and small molecules that target NK checkpoints.